Nanophase Technologies Co. (OTCMKTS:NANX – Get Free Report) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 400 shares, a growth of 33.3% from the March 31st total of 300 shares. Based on an average trading volume of 19,100 shares, the short-interest ratio is presently 0.0 days.
Nanophase Technologies Stock Down 2.9 %
Nanophase Technologies stock traded down $0.04 during mid-day trading on Tuesday, hitting $1.35. The company’s stock had a trading volume of 8,990 shares, compared to its average volume of 12,780. The company has a debt-to-equity ratio of 3.15, a quick ratio of 0.40 and a current ratio of 1.05. The business has a 50 day moving average price of $0.81 and a 200-day moving average price of $0.74. Nanophase Technologies has a 12 month low of $0.32 and a 12 month high of $1.49.
Nanophase Technologies (OTCMKTS:NANX – Get Free Report) last released its quarterly earnings data on Tuesday, April 23rd. The industrial products company reported $0.01 earnings per share (EPS) for the quarter. Nanophase Technologies had a negative net margin of 6.18% and a negative return on equity of 63.65%. The firm had revenue of $9.87 million for the quarter.
About Nanophase Technologies
Nanophase Technologies Corporation, a science-driven company, develops, manufactures, and sells integrated family of nanomaterial technologies in the United States. It engages in engineered materials, formulation development, and commercial manufacturing. The company produces engineered nanomaterial products comprising antimony, bismuth, cerium, iron, and zinc oxide for use in a various markets, including surface finishing,exterior coatings, personal care, plastics, scratch resistant coatings, and textiles.
Read More
- Five stocks we like better than Nanophase Technologies
- What is a Special Dividend?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Investing in large cap stocks: Diving into big caps
- Hilton Demonstrates Asset Light is Right for Investors
- How to Invest in the FAANG Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Nanophase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanophase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.